Abstract
Gastrodia elata Blume (G. elata), listed as one of the 34 precious Chinese medicines, servers a dual purpose as both a medicinal herb and a food source. Polysaccharide is the main active ingredient in G. elata, which has pharmacological activities such as immune regulation, anti-oxidation, anti-cancer, anti-aging, neuroprotection and antibacterial activity and so on. The biological activities of G. elata polysaccharide (GPs) is closely related to its chemical structures. However, no a review has synthetically summarized the chemical structures and pharmacological activities of GPs. This study delves into the chemical structures, pharmacological action of GPs, offering insights for the future development an application of these compounds.
1 Introduction
Gastrodiae Rhizoma (known as Tianma in China) is the dry tubers of G. elata Blume (G. elata), which was first mentioned in the Shen Nong’s Herbal Classic and was widely distributed in in Sichuan, Guangdong, Yunnan and Guizhou provinces (Wang et al., 2022). According to the theory of Traditional Chinese Medicine (TCM), G. elata nature is naturally warm and tastes sweet, returns to the liver meridian, which has the function of calming wind and stopping convulsive seizures, suppressing liver yang, expelling wind and clearing collateral. In clinical practice, G. elata is widely used in the prevention and treatment of childhood convulsions, memory loss, sciatic neuropathy, epilepsy and other diseases, and is also widely used in health products and food fields (Zhang et al., 2007). Modern pharmacology recognizes that G. elata and its extracts have anti-tumor, anti-oxidation and anti-aging effects, regulating immunity, sedation, hypoglycemia, hypolipidemia, anti-depression, anti-viral, and anti-convulsant effects (Liu and Huang, 2017).
Studies have shown that 134 bioactive compounds originate from G. elata, including phenolic compounds, polysaccharides, organic acids and sterols (Feng et al., 1979; Yang et al., 2007; Duan et al., 2013; Zhu et al., 2019). Some of these molecules showed activity against migraines, hypertension, and other neurological diseases (Hayashi et al., 2002; Zhu et al., 2019). It has been suggested that G. elata polysaccharides (GPs) are active compounds with a wide range of pharmacological effects, such as anti-oxidant, anti-cancer, anti-virus, anti-osteoporosis, immunomodulatory, and neuroprotective effects and so on (Qiu et al., 2007; Chen et al., 2015; Liu and Mori, 1992; Liu et al., 2015; Bao et al., 2017). Due to its great medical and health value, more and more researchers are paying attention to the pharmacological activities of GPs. Furthermore, many studies have attested that the biological activities of GPs are closely related to their chemical structures. However, no previous articles have synthetically summarized the chemical structures and pharmacological activities of GPs. In this article, we review the structural characteristics, biological activities and structure-activity relationships of GPs, to aid in providing a theoretical basis and data for the research, development and utilization of GPs.
2 The structural features of GPs
The structures of polysaccharides can be divided into primary structure and high-level structure. The primary structure includes molecular weight, monosaccharide composition, glycosidic bond configuration, repeating structural units and branching degree. The high-level structure (secondary, tertiary and quaternary structures) is mainly the spatial conformation of polysaccharides (Zhang et al., 2018). To date, more than 20Â GPs with known structures have been extracted and separated. The primary structural characteristics of the GPs, including molecular weight, monosaccharide composition, molar ratio, and backbone, are summarized in Table 1. The structures of the some GPs are shown in Figure 1.
TABLE 1
| Compound name | Molecular weight (Da) | Monosaccharide composition and molar ratio | Backbone | Ref. |
|---|---|---|---|---|
| WGEW | 1.00 × 105 | Glc | α-1,4-Glcp α-1,4,6-Glcp |
Qiu et al. (2007) |
| AGEW | 2.80 × 105 | Glc | α-1,4-Glcp α-1,4,6-Glcp |
Qiu et al. (2007) |
| GPs | 2.71 × 105 | Glc | α-1,4-Glcp | Bao et al. (2017) |
| GPSa | 4.97 × 105 | Rha: Man: Glc: 1: 1.07: 67.24 | α-1,4-Glcp | Zhu et al. (2010) |
| WTMA | 7.00 × 105 | Glc | α-1,4-Glcp α-1,4,6-Glcp |
Chen et al. (2011) |
| PGEB-3H | 2.88 × 104 | Glc | α-1,4-Glcp α-1,4,6-Glcp |
Ming et al. (2012) |
| Acidic polysaccharides | – | Xyl: Glc: GlcA: GlaA | – | Lee et al. (2012) |
| RGP-1a | 1.93 × 104 | Glc: Fru: 10.68: 1 | – | Chen et al. (2016) |
| RGP-1b | 3.92 × 103 | Glc | – | |
| PGE | 1.54 × 106 | Glc | α-1,4-Glcp α-1,4,6-Glcp α-1,3-Glcp |
Zhu et al. (2018) |
| GEP | 8.75 × 106 | Glc | – | Chen et al. (2018a) |
| GEP-3 | 2.52 × 104 | Glc | α-1,4-Glcp β-1,4-Glcp β-1,6-Glcp α-1,3,4-Glcp |
Huo et al. (2021) |
| GEP-1 | 2.01 × 105 | Glc | α-1,4-Glcp α-1,4,6-Glcp β-1,6-Glcp β-1,3-Glcp p-hydroxybenzyl alcoho |
Huo et al. (2021) |
| GEP-1 | 7.64 × 104 | Ara: Gal: Glc: Man: 2.189: 4.791: 92.035: 0.342 | α-1,4-Glcp | Guan et al. (2022) |
| GEPs | 2.90 × 105 | Glc: Gal: GlcA: 88.21: 4.48: 4.40 | α-1,4-Glcp | Li N. et al. (2023) |
| GaE-B | 2.15 × 105 | Man: Rha: Glc: Gal: Xyl: 5.36: 2.64: 77.35: 5.33: 9.34 | – | Ji et al. (2022) |
| GaE-R | 1.49 × 105 | Man: Rha: Glc: Gal: Xyl: 5.07: 3.18: 71.01: 6.41: 14.32 | – | Ji et al. (2022) |
| GaE-Hyb | 1.95 × 105 | Man: Rha: Glc: Gal: Xyl: 4.83: 3.02: 77.58: 4.76: 9.81 | – | Ji et al. (2022) |
| GaE-G | 2.51 × 105 | Man: Rha: Glc: Gal: Xyl: 3.64: 2.96: 81.88: 3.11: 8.40 | – | Ji et al. (2022) |
| GEP2-6 | 2.71 × 106 | Glc | α-1,4-Glcp α-1,6-Glcp |
Chen et al. (2024) |
The chemical structures of Gastrodia elata Blume polysaccharides.
Notes:–Indicates that the item is not detected; Glc: glucose, Man: mannose, Rha: rhamnose, Gal: galactose, Xyl: xylose, Fru: fructose, GlcA: glucuronic acid, GlaA: galacturonic acid.
FIGURE 1
Structures of GPs compounds in G. elata.
Qiu et al. (2007) obtained two glucans (WGEW and AGEW) from G. elata Blume., with molecular weight of AGEW and WGEW was 2.80 × 105 Da and 1.00 ×·105 Da, respectively. Their structures have an α-(1→4)-linked glucosyl backbone. Methylation analysis showed that two polysaccharides have terminal Glc, 1,4- and 1,4,6-linked Glc, the ratio of Glc:1,4-:1,4,6-linked Glc in WGEW was 1:16:1, and the ratio of it in AGEW was 1: 14: 1. Zhu et al. (2010) obtained G.elata polysaccharide (GPSa), with a molecular weight of 4.97 × 105 Da. Structural analysis revealed that GPSa was composed mainly of glucose, but also contained small amounts of rhamnose and mannose. The molar ratio of GPSa is rhamnose: mannose: glucose: 1: 1.07: 67.24. IR and NMR analysis indicated GPSa chain was α-(1→4) glucan with α-(1→4) glucosyl branches. Chen et al. (2011) also obtained water-soluble glucan (WTMA) from the rhizome of Gastrodia elata Bl. The mean molecular weight of WTMA was 7.0 × 105 Da, with the results showed that WTMA was an α-(1→4) glucan with α-(1→4) glucosyl branches attached to O-6 of the branch points. Ming et al. (2012) purified G. elata polysaccharide (PGEB-3H), was found to be a glucan with a molecular weight of 2.88 × 104 Da. Structural analysis showed that PGEB-3H was consisted of 1,4-linked glucose and 1,4,6-linked glucose with an approximate molar ratio of 20: 1. FT-IR analysis indicated a pyranose form of the glucosyl residue, absorption at 1027.0 cm−1, 1079.6 cm−1, and 1153.2 cm−1. Lee et al. (2012) obtained an acidic polysaccharide. It was purified from the crude polysaccharides by DEAE-Sepharose CL-6B. The analysis was shown that the fraction of acidic polysaccharide included xylose, glucose, galacturonic acid, and glucuronic acid (Table 1). Chen et al. (2016) separated two homogeneous polysaccharides (RGP-1a and RGP-1b) from the residue of Rhizoma gastrodiae. The results showed that RGP-1a was composed of fructose and glucose in a molar ratio of 1:10.68, and RGP-1b was mainly consisted of glucose. Bao et al. (2017) obtained a homogeneous polysaccharide (GPs), with a molecular weight of 2.71 × 105 Da. Analysis of the monosaccharide composition of GPs showed that GPs was composed of glucose. Zhu et al. (2018) yielded a polysaccharide (PGE) with hot water and purified it with Sephadex G-200 followed by ultra-filtration. This study indicated that PGE had a molecular weight of 1.54 × 106 Da, the backbone of PGE composed of (1→4)-linked-D-Glcp and the branches are (1→3)-linked-D-Glcp, (1→4,6)-linked-d-Glcp and (1→)-linked-glucose terminal. Further detailed data are shown in Table 1. Chen et al. (2018a) isolated a G. elata Blume polysaccharide (GEP), with a molecular weight of 8.75 × 106 Da. IR and NMR showed that GEP was consists of glucose. Huo et al. (2018) obtained a homogeneous polysaccharide which was named GEP-1. It was isolated and purified from G. elata by hot-water extraction, ethanol precipitation, and membrane separator. The structural analysis showed that the backbone of GEP-1 consisted of 1,3,6-linked-α-Glcp, 1,4-linked-α-Glcp, 1,4-linked-α-Glcp and 1,4,6-linked-α-Glcp, with a molecular weight of 2.01 × 105 Da, and contained a citric acid and repeating the p-hydroxybenzyl alcohol as a branch. Guan et al. (2022) isolated a polysaccharide from G. elata (named GEP-1), with a molecular weight of 7.64 × 105 Da. NMR and methylation analyses revealed that the main chain structure of GEP-1 was α-(1→4)-glucans. Li F. et al. (2013) obtained a polysaccharide named GEPs, with a molecular weight of 2.92 × 105 Da, which consists of glucose, galactose and galacturonic acid was in the ratio of 88.21: 4.48: 4.40. Ji et al. (2022) obtained four components of GaE-B (G. elata Bl. f. glauca S. chow polysaccharides), GaE-R (G. elata Bl. f. elata polysaccharides), GaE-Hyb (hybridization of G. elata Bl. f. glauca S. chow and G. elata Bl. f. elata polysaccharides), and GaE-G (G. elata Bl. f. viridis Makino polysaccharides). Based on HPGPC analysis, their average molecular weight are 2.15 × 105 Da, 1.49 × 105 Da, 1.95 × 105 Da, 2.51 × 105 Da, respectively. GC analysis showed that these GaE polysaccharides were heteropolysaccharides, and the polysaccharides comprised Man, Rha, Glc, Gal, and Xyl. The detail more ratio shown in Table 1. Chen et al. (2024) obtained a water-soluble polysaccharide (GEP2-6), with a molecular weight of 2.71 × 106 Da, which consists of only glucose. NMR and methylation analyses revealed that the main chain structure of GEP2-6 was consists of α-(1→4) and α-(1→6) glycosidic bonds.
3 Biological activities
In recent years, research has focused on the pharmacodynamics of GPs. Many references point out that GPs showed that significant pharmacological activies, sush as anti-oxidation, anti-tumor, immune regulation, anti-aging, improve memory, improve cerebral ischemia, reduce blood pressure, anti-bacterial effect and reduce blood lipid (Figure 2) (Zhu et al., 2019; Wang et al., 2022). The biological activities of GPs are summarized in Table 2.
FIGURE 2
The health functions of GPs.
TABLE 2
| Biological activies | Name | Description | In vivo/In vitro | Ref. |
|---|---|---|---|---|
| Anti-oxidative activity | GP | evaluated the scavenging activity of DPPH and ABTS. | In vitro | Hou and Hou (2018) |
| heteropolysaccharides | tested the activites of DPPH radicals, ABTS radicals, superoxide radicals, hydroxyl radicals, ferrous ion chelating capacity, and reducing power | In vitro | Ji et al. (2022) | |
| GPs | The scavenging rate of DPPH and ABTS was higher, and the antioxidant capacity was lower than that of Vc | In vitro | Wang et al. (2022) | |
| GEP1-G GEP2-G | The clearance rates of DPPH were 44.5% and 25.6%, the clearance rates of O2-· were 33.32% and 21.55%, the clearance rates of ·OH were 39.5% and 22.8% | In vitro | Chen et al. (2018b) | |
| GPs | the clearance rate of DPPH and ·OH was 40.52% and 36.52% | In vitro | Zhang et al. (2021) | |
| GPs | has the best removal effect on hydrogen peroxide (H2O2), the clearance rates was 25.80% | In vitro | Xu et al. (2015) | |
| GPs | the concentration IC50 were 1.18 mg/mL (·OH), 1.62 mg/mL (O2-·) | In vitro | Liu et al. (2009) | |
| GPs | has a certain scavenging effect on ferrous ions, ABTS free radicals, hydroxyl free radicals and DPPH free radicals | In vitro | Zhang et al. (2019) | |
| GEP2-6 | scavenged DPPH and hydroxyl radicals | In vitro | Chen et al. (2024) | |
| Anti-aging activity | GEP | reduced the MDA level, increased the SOD and GSH-Px activities | In vivo | Chen et al. (2018c) |
| GPs | increased SOD and GSH-Px activity and decreased MDA and NO content | In vivo | Li F. et al. (2013) | |
| GPs | related to oxidative metabolism in the body | In vivo | Xie et al. (2010) | |
| GPs | increased the activities of SOD and CAT in serum, liver, brain and heart | In vivo | Kong et al. (2005) | |
| GPs | decreased the mRNA expression and protein level of caspase-3, MURF-1 and MAFbX | In vivo | Wang et al. (2019) | |
| Anti-tumor activity | WTMA | inhibited PANC-1 cell growth, showed no effect on PANC-1 cells growth | In vitro | Chen et al. (2011) |
| GPs | inhibited at 90Â mg/kg, and the inhibition rate was 27.6% | In vitro | Wang et al. (2014) | |
| GPs | increased G0/G1 phase and decrease G2/M phase | In vitro | Liu et al. (2015) | |
| WSS25 | blocked of BMP/Smad signaling pathway | In vitro | Qiu et al. (2010) | |
| PGEs | promoted late apoptosis and arrested at G2/M phase | In vitro | Dai et al. (2021) | |
| Immunological activity | RGP-1a RGP-1b | effected the NO production and phagocytic activity | In vitro | Chen et al. (2016) |
| GPs | indreased the serum IL-2, TNF-a, IFN-g, IgG, IgA, IgM levels, and the spleen and thymus indexes | In vivo | Bao et al. (2017) | |
| GEP-1 | induced TNF-α, IL1-β and NO release | In vitro | Guan et al. (2022) | |
| GEPs | increased content of SCFAs | In vitro | Li N. et al. (2023) | |
| GPs | regulated the levels of IgA, IgG, IgM and hemolysin in mice, increased the index of thymus and spleen |
In vitro
In vivo |
Dai et al. (2021) | |
| GPs | reduced the activity of ALT, AST, NO and the contents of TNF-α and IL-1 in serum of mice, inhibited MAD, increased SOD. |
In vitro
In vivo |
Li et al. (2015) | |
| GPs | stimulated IL-2, TNF-α, IFN-γ, IgG, IgA and IgM | In vivo | Li et al. (2016) | |
| Neuroprotective activity | GPs | decreased BCL-12 and BAX protein, inhibited the expression of caspase-3 protein | In vitro | Zhou et al. (2013) |
| GPs | reduced the level of intracellular toxic reactive oxygen species, reduced the release of LDH, inhibited the expression of GRP 78, X-BP-1, GADD153, caspase-9 and caspase-12 | In vitro | Zhou et al. (2017) | |
| NPGE | attenuated ferroptosis-mediated neuroinflammation via the NRF2/HO-1 signaling pathway | In vitro | Zhang et al. (2023) | |
| GPs | increased Bcl-2 expression in brain tissue, reduced the expression of Bax | In vitro | Wang et al. (2019) | |
| Hypotensive effects | GPs | reduced systolic blood pressure in SHR fed a high-fat diet | In vitro | Lee et al. (2012) |
| PGE | exhibited ACE-inhibitory activity | In vitro | Zhu et al. (2018) | |
| GPs | decreased the levels of Ang II, and increased the levels of NO were increased | In vitro | Wang et al. (2019) | |
| Antihyperlipidemic effects | PGEB-3H | caused 29% increase in HDL-C | In vitro | Ming et al. (2012) |
| GPs | decreased hypolipidemic indexes (total cholesterol, triglyceride and low-density lipoprotein cholesterol levels) | In vivo | Lee et al. (2012) | |
| PGEB-3-H | decreased the content of TC and TG and increased HDL-C, had no significant effect on the content of LDL-C | In vitro | Miao and Shen (2006) |
Biological activities of GPs isolated from the Gastrodia elata.
3.1 Anti-oxidation activities
Free radicals can accelerate the oxidation process in vivo and lead to cell aging. Previous studies have shown that GPs can effectively remove free radicals including 1,1-diphenyl-2-picrylhydrazyl (DPPH), oxygen radicals (O2-·), and hydroxyl radicals (·OH). GPs has good antioxidant activity, as evaluated by DPPH, O2-·and·OH assays. The clearance rate of DPPH, O2-·and OH was around 50%, when the concentration of GPs was 1–3.5 mg/mL (Hou and Hou, 2018; Chen et al., 2018b; Zhang et al., 2021; Chen et al., 2024; Liu et al., 2009; Wang, et al., 2022). Xu et al. (2015) reported that GPs had the best removal effect on hydrogen peroxide (H2O2), the clearance rates was 25.80%, and the scavenging power of other free radicals as following DPPH (22.37%) > ONOO− (20.52%) > O2- (12.23%) > -OH (4.85%). Chen et al. (2018a) found GEP had high radical-scavenging activities. At concentration of 200 mg/mL, the HRSA and DRSA of the GEP were 94.56% and 84.21%, respectively. In addition, GPs have a strong scavenging effects on ABTS radicals, superoxide radicals, ferrous ion chelating capacity, and reducing power (Hou and Hou, 2018; Zhang et al., 2019; Ji et al., 2022; Wang, et al., 2022). The above studies showed that GPs had a strong antioxidant effect. The antioxidant range of heteropolysaccharides is wider than that of glucan from G. elata.
3.2 Anti-aging activities
Many studies have shown that GPs can improve the expression of peroxidase and slow down the aging of organs and tissue. Li N. et al. (2023) reported that GPs had anti-aging effects in D-galactose-induced senescence mice. GPs significantly increased SOD and GSH-Px activity and decreased MDA and NO contents in aging mice, and showed a good dose-dependent relationship. Xie et al. (2010) found that GPs can improve the learning and memory ability of D-galactose-induced aging mice, its mechanism is mainly related to oxidative metabolism in the body. The finding of Kong et al. (2005) displayed that GPs significantly increased the activities of SOD and CAT in the serum, liver, brain and heart tissue of aging mice, significantly inhibited the formation of MDA in the serum, liver, brain and heart tissue of aging mice, and significantly increased the activity of GSH-Px in the serum of aging mice. The results indicated that GPs had better scavenging free radicals, decreasing MDA content and delaying cell aging. Chen et al. (2018b) found that intragastric administration of GEP significantly decreased the MDA levels but significantly increased SOD and GSH-Px activities in the sera and brains of D-galactose-induced aging mice as compared with those of the model group, indicated that GEP can effectively suppress oxidation-induced damage to the sera and brain tissues of D-galactose-induced aging mice. Wang and Liu (2019) found that GPs could delay skeletal muscle aging in mice by reducing the mRNA expression and protein levels of caspase-3, MURF-1 and MAFbX in muscle tissue. However, the molecular mechanism of anti-aging is not been clarified.
3.3 Anti-tumor activities
Numerous cell and animal model studies have shown that GPs can significantly inhibit the development of various types of cancer, such as colon cancer, liver cancer, pancreatic cancer, etc. Wang et al. (2014) found that the tumor growth of GPs was significantly inhibited at 90Â mg/kg, and the inhibition rate was 27.6%. Liu et al. (2015) reported that GPs have a significant anti-cancer effect on H22 tumor-bearing mice, the results showed that the GPs inhibition rate on H22 cells was 44.7%. The mechanism is mainly related to GPs could increase the cell percentage in the G0/G1 phase and decrease cell percentage in the G2/M phase. Qiu et al. (2010) reported that WSS25 could inhibit the growth of xenografted hepatocellular cancer cells in nude mice, its mechanism is related to the blocking of BMP/Smad signaling by WSS25, as shown in Figure 3. Dai et al. (2021) investigated the anti-tumor activities of G. elata polysaccharides (PGEs) against MCF-7 cells in vitro. The results showed that the PGEs could inhibit the growth of MCF-7 cells by promoting late apoptosis and arresting at G2/M phase. Chen et al. (2011) investigated the anti-pancreatic cancer activities of WTMA against PANC-1 cell lines and showed no effect on the growth of PANC-1 cells.
FIGURE 3
The mechanism of WSS25 in hepatocellular cancer cell lines.
3.4 Immunological activities
Numerous in vitro and in vivo studies have demonstrated the immunological activities of GPs. Li et al. (2016) found that GPs can regulate the levels of immunoglobulin (IgA, IgG, IgM) and hemolysin in mice, and increase the index of thymus and spleen. Li et al. (2015) reported that GPs significantly reduced the activity of ALT, AST, NO and the content of TNF-α and IL-1 in the serum of mice, inhibited the level of MAD in the liver, increased the activity of SOD and the concentration could significantly increase the proliferation ability of T and B lymphocytes in the spleen. The results indicated that GPs had a good protective effect against immunological liver injury in mice. Li F. et al. (2013) found that GEPs can effectively alleviate immunosuppression, the potential mechanism was related to the modulation of gut microbiota composition by GEPs and the resulting increased content of SCFAs. Chen et al. (2016) found that the two polysaccharides (RGP-1a and RGP-1b) have a significant impact on NO production and phagocytic activity of RAW264.7 macrophages. Compared to RGP-1a, RGP-1b, which has a smaller molecular weight and a uniform monosaccharide composition, exhibits superior immunological activities in RAW264.7 macrophages. Molecular weight and homogeneous composition may be key factors affecting the immunological activity of GPs. Bao et al. (2017) found that GPs can increase serum IL-2, TNF-α, IFN-g, IgG, IgA and IgM levels, as well as spleen and thymus indices of Kunming mice, showing that GPs could improve the immune function of immunosuppression model mice. Guan et al. (2022) observed the effect of GEP-1 on immune function by increasing phagocytic activities and induced release of cytokines (TNF-α, IL1-β) and nitric oxide (NO) in macrophages.
3.5 Neuroprotective activities
The neuroprotective effect of GPs on rat pheochromocytoma nerve cells (PC12) has recently attracted great attention. Zhou et al. (2013) found that GPs significantly could improve corticosterone (CORT)-induced injury and cell morphology of PC12 cells, reduce the expression of BCL-12 and BAX protein, and inhibit the expression of caspase-3 protein. Zhou et al. (2017) reported that GPs play a protective role in nerve cells by reducing the level of intracellular toxic reactive oxygen species, reducing the release of LDH, and inhibiting the expression of GRP 78, X-BP-1, GADD153, caspase-9 and caspase-12. Zhang et al. (2023) reported that neutral polysaccharide from G. elata (NPGE) had potential effects on the neuropathology of cerebral ischemia-reperfusion injury (CIRI). Its mechanism is related to that NPGE alleviates CIRI by attenuating ferroptosis-mediated neuroinflammation via the NRF2/HO-1 signaling pathway, the relevant mechanism is shown in Figure 4. In addition, GPs could increase the expression of anti-apoptotic gene Bcl-2 in brain tissue reduce expression of apoptosis gene Bax, alleviating cerebral palsy, apoptosis of brain tissue, exerting neuroprotective activity (Wang et al., 2019).
FIGURE 4
Schematic illustration of NPGE in BC cells through of the NRF2/HO-1 pathway.
3.6 Hypotensive effects
Numerous studies have demonstrated the blood pressure lowering effect of GPs. Angiotensin-converting enzyme (ACE) plays a significant role in the development of hypertension in the body. Miao and Shen (2006) observed the effect of GPs on angiotensin â…¡ (Ang â…¡) level, the results showed that Ang II levels were decreased and the NO levels were increased. Zhu et al. (2018) found that PGE had ACE inhibitory activity, the inhibition rate of PGE on ACE was calculated to be 74.40% and the IC50 value was 0.66Â mg/mL. Lee et al. (2012) reported that the acidic polysaccharide fraction from Gastrodia rhizome significantly reduced blood pressure in SHR fed a high-fat diet.
3.7 Antihyperlipidemic effect
Ming et al. (2012) reported effects of PGEB-3-H on total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C). The results showed that PGEB-3-H could reduce the content of TC and TG and increase the level of HDL-C, but had no significant effect on the LDL-C content. It can be seen that PGEB-3-H has a potential effect on lowering blood lipids and is related to the regulation of cholesterol content. Lee et al. (2012) studies showed that the hypolipidemic indexes (total cholesterol, triglyceride and low-density lipoprotein cholesterol levels) of the acidic polysaccharide groups were lower than those in the control group. These results indicated that acidic polysaccharide improve serum lipid levels.
3.8 Other activities
GPs has various structures and diverse pharmacological effects. A large number of studies have shown that GPs play an effective role in anti-bacterial activity, osteoporosis prevention, liver protective effects, memory improvement and skin care effectiveness. Chen et al. (2018c) found that GPs had an inhibitory effect on G−, G+ and fungi. Chen et al. (2015) investigated that a sulfated polysaccharide (WSS25) extracted from the rhizome of G. elata inhibited RANKL-induced osteoclast formation in RAW264.7 cells and BMMs by blocking the BMP-2/Smad/Id1 signaling pathway. Shi et al. (2017) reported that GPs could improve the memory of rats with cerebral palsy by regulating neurotransmitter in the brain. A number of studies have applied GPs to develop a skin care product (Wang et al., 2016; Du and Chen, 2018; Zheng et al., 2018). Qiu et al. (2007) reported that WGEW and AGEW showed strong anti-dengue virus bioactivity. Chen et al. (2024) found that four heteropolysaccharides had an inhibitory effect on the anti-hyperglycaemic activity of α-amylase and α-glucosidase. Xu et al. (2023) reported that GPs had modulation of gut microbiota and improvement in metabolic disorders.
4 Conclusion
In conclusion, as a traditional Chinese medicine, G. elata is widely used in medicine, food and health products. G. elata polysaccharides are one of the main components of G. elata. Due to its pharmacological effects such as anti-oxidation, anti-tumor, immune regulation and memory improvement, it has attracted great attention from scientists in medicine and healthcare fields. In this paper, structural analysis and pharmacological activities of related research, further study of G. elata polysaccharides and rational application for reference.
Statements
Author contributions
LY: Writing–original draft, Writing–review and editing. S-HQ: Writing–original draft. C-TZ: Writing–original draft, Writing–review and editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (31960075 and 21602196), the Yunnan Province Agricultural Bisic Research Joint Foundation (202101BD070001-028), and the Yunnan Ten Thousand Talents Plan Young and Elite Talents Project (YNWR-QNB J-2020-178).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
Bao Q. W. Qian L. Gong C. Shen X. Z. (2017). Immune-enhancing activity of polysaccharides from Gastrodia elata. J. Food. Process. Pres.41, 13016. 10.1111/jfpp.13016
2
Chen C. Qin Y. Fang J. P. Ni X. Y. Yao J. Wang H. Y. et al (2015). WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling. Acta Pharmacol. Sin.36, 1053–1064. 10.1038/aps.2015.65
3
Chen J. C. Tian S. Shu X. Y. Du H. T. Li N. Wang J. R. (2016). Extraction, characterization and immunological activity of polysaccharides from Rhizoma gastrodiae. Int. J. Mol. Sci.17, 1011. 10.3390/ijms17071011
4
Chen J. Q. Miao W. Liu Y. Zhou J. Han J. Zhang L. et al (2024). Structural characterization, molecular dynamic simulation, and conformational visualization of a water-soluble glucan with high molecular weight from Gastrodia elata Blume. Int. J. Biol. Macromol.263, 130207. 10.1016/j.ijbiomac.2024.130207
5
Chen L. Zhang Y. P. Jin L. X. (2018a). Preparation, characterization and anti-ageing activity of Gastrodia elata Blume polysaccharide. Acta Aliment.47 (2), 210–219. 10.1556/066.2018.47.2.10
6
Chen S. Li X. X. Fu Y. D. Liu X. Zheng H. X. Wu S. Q. et al (2018b). Study on antibacterial activity of Gastrodia polysaccharides from Hanzhong. Jiangsu Agri. Sci.46 (11), 156–159. 10.15889/j.issn.1002-1302.2018.11.041
7
Chen S. Li X. X. Xu Y. M. Lin B. B. Zhou T. H. Liu X. et al (2018c). Extraction, purification and antioxidant activity of polysaccharides from Gastrodia elata B1. Chin. J. Clin. Pharmacol.34 (18), 2203–2206. 10.13699/j.cnki.1001-6821.2018.18.020
8
Chen X. Cao D. X. Zhou L. Jin H. Y. Dong D. Yao J. et al (2011). Structure of a polysaccharide from Gastrodia elata Bl., and oligosaccharides prepared thereof with anti-pancreatic cancer cell growth activities. Carbohydr. Res.86, 1300–1305. 10.1016/j.carbpol.2011.06.029
9
Dai S. S. Zhang W. H. Dou Y. W. Liu H. M. Chen X. Shi J. H. et al (2021). Towards a better understanding of the relationships between the structure and antitumor activity of Gastrodia elata polysaccharides by asymmetrical flow field-flow fractionation. Food Res. Int.149, 110673. 10.1016/j.foodres.2021.110673
10
Du S. J. Chen D. L. (2018). Extraction of polysaccharides from Tianma stem and preparation of moisturizer. Yunnan Chem. Tech.45, 102–104.
11
Duan X. H. Li Z. L. Yang D. S. Zhang F. L. Lin Q. Dai R. (2013). Study on the chemical constituents of Gastrodia elata. J. Chin. Med. Mater.36 (10), 1608–1611. 10.13863/j.issn1001-4454.2013.10.022
12
Feng X. Z. Chen Y. W. Yang J. S. (1979). Study on the chemical composition of Tianma. Hua Hsueh Hsueh Pao37, 175–182.
13
Guan H. Ling X. Xu J. Zhu Y. Q. Zhang J. Y. Liu X. Y. (2022). Structural characterization of polysaccharide derived from Gastrodia elata and its immunostimulatory effect on RAW264.7 cells. Molecules27, 8059. 10.3390/molecules27228059
14
Hayashi J. Sekine T. Deguchi S. Lin Q. Horie S. Tsuchiya S. et al (2002). Phenolic compounds from Gastrodia rhizome and relaxant effects of related compounds on isolated smooth muscle preparation. Phytochem59, 513–519. 10.1016/S0031-9422(02)00008-0
15
Hou M. N. Hou S. P. (2018). Experimental study on antioxidant activity of Gastrodia polysaccharides from Shaanxi Province. Shaanxi J. Agr. Sci.64 (6), 31–32.
16
Huo J. J. Lei M. Li F. F. Hou J. J. Zhang Z. J. Long H. L. et al (2021). Structural characterization of a polysaccharide from Gastrodia elata and its bioactivity on gut MicrobiotaAvailable. Int. J. Biol. Macromol.186, 501–509. 10.1016/j.ijbiomac.2021.06.157
17
Ji N. Liu P. Zhang N. Yang S. Y. Zhang M. S. (2022). Comparison on bioactivities and characteristics of polysaccharides from four varieties of Gastrodia elata Blume. Front. Chem.10, 956724. 10.3389/fchem.2022.956724
18
Kong X. W. Liu T. Y. Guan J. (2005). Effect of polysaccharide from the Gastrodia eleta Blume on metabolism of free redicals in subacute aging modelm ice. J. Anhui Univ. Nat. Sci. Ed.29 (2), 95–99.
19
Lee O. H. Kim K. I. Han C. K. Kim Y. C. Hong H. D. (2012). Effects of acidic polysaccharides from Gastrodia rhizome on systolic blood pressure and serum lipid concentrations in spontaneously hypertensive rats fed a high-fat diet. Int. J. Mol. Sci.13, 698–709. 10.3390/ijms13010698
20
Li F. Zhu J. P. Wang Y. M. Shen Y. S. (2013). Study on anti-senility effect of polysaccharide from Gastrodia elata Bl. J. West Anhui Univ.29 (5), 12–14.
21
Li F. Zhu J. P. Wang Y. M. Zhou E. H. Shen Y. S. (2015). Protection effect of polysaccharides from Gastrodia elata Bl. on the immunological liver injury in mice. Pharmacol. Clin. Chin. Med.31 (1), 111–113.
22
Li N. Wang D. Wen X. J. Chu R. Fan J. Y. Chen Y. L. et al (2023). Effects of polysaccharides from Gastrodia elata on the immunomodulatory activity and gut microbiota regulation in cyclophosphamide-treated mice. J. Sci. Food Agric.103, 3390–3401. 10.1002/jsfa.12491
23
Li X. B. Zhan J. P. Zhang Y. T. Xie Z. L. Zhu Y. Q. Chen Y. L. et al (2016). Effect of polysaccharide from Gastrodia Elata B1 on humoral immune function in immunosuppressed mice induced by cyclophosphamide. Chin. J. Gerontol.36 (5), 1027–1028.
24
Liu J. Mori A. (1992). Antioxidant and free radical scavenging activities of Gastrodia elata Bl. and Uncaria rhynchophylla (Miq.) Jacks. Neuropharmacology31, 1287–1298. 10.1016/0028-3908(92)90058-W
25
Liu M. X. Li Q. F. Liu Q. Huang Z. Q. Qiu F. (2009). Study on extraction technology, structure and free radical scavenging activity of polysaccharides from Gastrodia elata B1. Food Sci.30 (3), 29–32. 10.1360/972009-1551
26
Liu X. H. Guo X. N. Zhan J. P. Xie Z. L. Wang J. M. Zhang Y. T. et al (2015). The effects of polysaccharide from Gastrodia elata B1 on cell cycle and caspase proteins activity in H22 tumor bearing mice. Chin. J. Gerontol.20, 5681–5682.
27
Liu Y. Huang G. L. (2017). The chemical composition, pharmacological effects, clinical applications and market analysis of Gastrodia elata. Pharm. Chem. J.51, 211–215. 10.1007/s11094-017-1584-5
28
Miao H. C. Shen Y. S. (2006). Antihypertensive effect of polysaccharides substracted from Gastrodia elata Blume. Chin. J. Hypertens.4 (7), 531–534. 10.1016/S1872-2040(06)60020-0
29
Ming J. Liu J. Wu S. Guo X. Chen Z. Zhao G. (2012). Structural characterization and hypolipidemic activity of a olysaccharide PGEB-3H from the fruiting bodies of Gastrodia elata Blume. Procedia. Eng.37, 169–173. 10.1016/j.proeng.2012.04.221
30
Qiu H. Tang W. Tong X. K. Ding K. Zuo J. P. (2007). Structure elucidation and sulfated derivatives preparation of two α-D-glucans from Gastrodia elata, and their anti-dengue virus bioactivities. Carbohydr. Res.342, 2230–2236. 10.1016/j.carres.2007.06.021
31
Qiu H. Yang B. Pei Z. C. Zhang Z. Ding K. (2010). WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling. J. Biol. Chem.285 (42), 32638–32646. 10.1074/jbc.M110.105544
32
Shi H. He Q. Lou Y. J. Shao S. J. (2017). Effect of gastrodiae rhizoma polysaccharide on brain neutral transmitter in immature rats with cerebral palsy. Chin. J. Exp. Tradit. Med. Formulae.23 (23), 140–145.
33
Wang C. Q. Yang Y. Tang C. He X. R. (2022). Research progress on extraction, separation and pharmacological activities of rhizoma gastrodiae polysaccharide. Chin. Pharm. Aff.36 (4), 417–428. 10.16153/j.1002-7777.2022.04.007
34
Wang Q. Zhang Y. Li J. Re T. L. (2014). The inhibition effect of polysaccharides from Gastrodia Elata Bl on tumor growth though immune system. Immunol. J.30 (6), 566–568. 10.13431/j.cnki.immunol.j.20140124
35
Wang X. L. Liu P. D. Zhang L. Xie Y. Yang C. Yu Q. (2019). Effect of gastrodiae rhizoma polysaccharide on neuronal apoptosis gene expression in brain tissue of cerebral palsy newborn rats. Clin. Basic Bridg. Res.35 (18), 2062–2064. 10.13699/j.cnki.1001-6821.2019.18.027
36
Wang X. M. Liu K. X. (2019). Experimental study of the effects of Gastrodia elata polysaccharide on delay in skeletal muscle aging. J. Zunyi Med. Univers.42 (2), 135–140. 10.14169/j.cnki.zunyixuebao.2019.0027
37
Wang Y. Zan L. X. Hu L. L. Xu H. Yang P. J. Zhao H. et al (2016). Formulation study of O/W creams cosmetics Tianma crude extract. Asia-Pac. Tradit. Med.12, 21–23. 10.11954/ytctuu.201617009
38
Xie X. Y. Chao Y. M. Du Z. Zhang Y. (2010). Effects of polysaccharides from Gastrodia elata on anti-aging of ageing Mice. Pharm. J. Chin. PLA.26, 206–209. 10.3969/jissn.1008-9926.2010.03.06
39
Xu D. Wu Q. Y. Liu W. Y. Hu G. M. Meng H. H. Wang J. S. (2023). Therapeutic efficacy and underlying mechanisms of Gastrodia elata polysaccharides on dextran sulfate sodium-induced inflammatory bowel disease in mice: modulation of the gut microbiota and improvement of metabolic disorders. Int. J. Biol. Macromol.248, 125919. 10.1016/j.ijbiomac.2023.125919
40
Xu L. Huang Y. S. Zhu Q. J. Wang R. M. Ye C. (2015). Extraction and scavenging free radical effects of polysaccharides from Gastrodia elata. Guangdong Agri. Sci.42 (21), 117–123. 10.16768/j.issn.1004-874x.2015.21.029
41
Yang X. D. Zhu J. Yang R. Liu J. P. Li L. Zhang H. B. (2007). Phenolic constituents from the rhizomes of Gastrodia elata. Nat. Prod. Res.21, 180–186. 10.1080/14786410601081997
42
Zhang G. Xu C. Y. Xu M. Zhang X. F. (2019). Study on extraction and antioxidant activity of Gastrodia polysaccharide. Agri. Dev. Equip.6, 118–119.
43
Zhang M. J. Xu H. D. An X. G. (2007). Research on ultrasonic wave extraction of Gastrodia elata Bl. Polysaccharides. J. Nat. Sci. Ed.35 (4), 91–95.
44
Zhang R. X. Zhang Y. H. Zhou Y. C. Qi Y. (2018). Research progress on the chemical structure and pharmacological effects of polysaccharides from traditional Chinese medicine. Heilongjiang J. Tradit. Chin. Med.47 (1), 88–89.
45
Zhang S. Q. Liu L. He N. W. Zhao Y. (2021). Gastrodia elata polysaccharide from Shaanxi by ultrasound-assisted hot water extraction: process optimization and antioxidant activity. Chin. Agri.Sci. Bull.37 (9), 131–136.
46
Zhang Y. G. Ye P. Zhu H. Gu L. J. Li Y. T. Feng S. et al (2023). Neutral polysaccharide from Gastrodia elata alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis-mediated neuroinflammation via the NRF2/HO-1 signaling pathway. CNS Neurosci. Ther.30, 14456–e14514. 10.1111/cns.14456
47
Zheng J. Sun M. M. Hu A. J. Hu X. H. Ren Y. Y. Yu S. Y. (2018). Extraction of polysaccharide from Gastrodia elata Blume and preparation of its drinks. Food Res. Dev.39, 123–128. 10.3969/j.issn.1005-6521.2018.04.022
48
Zhou B. H. Liang Y. X. Shen H. Liu G. Tu J. (2013). Study on the protective mechanism of Gastrodia polysaccharide on PC12 cells damaged by corticosterone. J. Chin. Med. Mater.36 (4), 630–633.
49
Zhou B. H. Tan J. Zhang C. Wu Y. (2017). Neuroprotective effect of polysaccharides from Gastrodia elata Blume against corticosterone induced apoptosis in PC12 cells via inhibition of the endoplasmic reticulum stress mediated pathway. Mol. Med. Rep.28 (17), 1182–1190. 10.3892/mmr.2017.7948
50
Zhu H. Liu C. Hou J. Long H. Wang B. Guo D. et al (2019). Gastrodia elata Blume polysaccharides: a review of their acquisition, analysis, modification, and pharmacological activities. Molecules24, 2436. 10.3390/molecules24132436
51
Zhu X. X. Zhang Y. Luo X. G. (2010). Studies on structure characterization of Gastrodia elata BL polysaccharides. Food Res. Dev.31 (09), 52–56.
52
Zhu Z. Y. Chen C. J. Sun H. Q. Chen L. J. (2018). Structural characterisation and ACE-inhibitory activities of polysaccharide from Gastrodia elata Blume. Nat. Prod. Res.33 (12), 1721–1726. 10.1080/14786419.2018.1434643
Summary
Keywords
Gastrodia elata , polysaccharides, chemical structure, pharmacological activity, mechanism
Citation
Yang L, Qin S-H and Zi C-T (2024) Research progress of Gastrodia elata Blume polysaccharides: a review of chemical structures and biological activities. Front. Chem. 12:1395222. doi: 10.3389/fchem.2024.1395222
Received
03 March 2024
Accepted
03 June 2024
Published
02 July 2024
Volume
12 - 2024
Edited by
Bhaskar R. Sathe, Dr. Babasaheb Ambedkar Marathwada University, India
Reviewed by
Venkata Reddy Udumula, Emory University, United States
Kunming Qin, Jiangsu Ocean Universiity, China
Zhenhua Liu, Henan University, China
Updates
Copyright
© 2024 Yang, Qin and Zi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Cheng-Ting Zi, zichengting@126.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.